These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23192179)

  • 1. Digenic inheritance and Mendelian disease.
    Lupski JR
    Nat Genet; 2012 Dec; 44(12):1291-2. PubMed ID: 23192179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered gene silencing and human diseases.
    Perini G; Tupler R
    Clin Genet; 2006 Jan; 69(1):1-7. PubMed ID: 16451126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2.
    Lemmers RJ; Tawil R; Petek LM; Balog J; Block GJ; Santen GW; Amell AM; van der Vliet PJ; Almomani R; Straasheijm KR; Krom YD; Klooster R; Sun Y; den Dunnen JT; Helmer Q; Donlin-Smith CM; Padberg GW; van Engelen BG; de Greef JC; Aartsma-Rus AM; Frants RR; de Visser M; Desnuelle C; Sacconi S; Filippova GN; Bakker B; Bamshad MJ; Tapscott SJ; Miller DG; van der Maarel SM
    Nat Genet; 2012 Dec; 44(12):1370-4. PubMed ID: 23143600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facioscapulohumeral Dystrophy.
    Wang LH; Tawil R
    Curr Neurol Neurosci Rep; 2016 Jul; 16(7):66. PubMed ID: 27215221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When enough is enough: genetic diseases associated with transcriptional derepression.
    Gabellini D; Green MR; Tupler R
    Curr Opin Genet Dev; 2004 Jun; 14(3):301-7. PubMed ID: 15172674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic mechanisms of facioscapulohumeral muscular dystrophy.
    de Greef JC; Frants RR; van der Maarel SM
    Mutat Res; 2008 Dec; 647(1-2):94-102. PubMed ID: 18723032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An epigenetic basis for genetic anticipation in facioscapulohumeral muscular dystrophy type 1.
    Zheng F; Qiu L; Chen L; Zheng Y; He Q; Lin X; Lin M; Lin Y; Fu Y; Wang N; Wang Z
    Brain; 2023 Dec; 146(12):e107-e110. PubMed ID: 37352893
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply: An epigenetic basis for genetic anticipation in facioscapulohumeral muscular dystrophy type 1.
    Erdmann H; Scharf F; Hallermayr A; Barseghyan H; Walter MC; Holinski-Feder E; Schoser B; Abicht A
    Brain; 2023 Dec; 146(12):e111-e114. PubMed ID: 37348868
    [No Abstract]   [Full Text] [Related]  

  • 9. Epigenetics in facioscapulohumeral muscular dystrophy (FSHD).
    Claustres M
    Hum Mutat; 2009 Oct; 30(10):v. PubMed ID: 19787630
    [No Abstract]   [Full Text] [Related]  

  • 10. The Genetics and Epigenetics of Facioscapulohumeral Muscular Dystrophy.
    Himeda CL; Jones PL
    Annu Rev Genomics Hum Genet; 2019 Aug; 20():265-291. PubMed ID: 31018108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Facioscapulohumeral muscular dystrophy type 2].
    Sacconi S; Desnuelle C
    Rev Neurol (Paris); 2013; 169(8-9):564-72. PubMed ID: 23969240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case Studies on the Genetic and Clinical Diagnosis of Facioscapulohumeral Muscular Dystrophy.
    Hamel J; Tawil R
    Neurol Clin; 2020 Aug; 38(3):529-540. PubMed ID: 32703466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Epigenetic Regulator SMCHD1 in Development and Disease.
    Jansz N; Chen K; Murphy JM; Blewitt ME
    Trends Genet; 2017 Apr; 33(4):233-243. PubMed ID: 28222895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monosomy 18p is a risk factor for facioscapulohumeral dystrophy.
    Balog J; Goossens R; Lemmers RJLF; Straasheijm KR; van der Vliet PJ; Heuvel AVD; Cambieri C; Capet N; Feasson L; Manel V; Contet J; Kriek M; Donlin-Smith CM; Ruivenkamp CAL; Heard P; Tapscott SJ; Cody JD; Tawil R; Sacconi S; van der Maarel SM
    J Med Genet; 2018 Jul; 55(7):469-478. PubMed ID: 29563141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Epigenetic Regulators of DUX4-fl for Targeted Therapy of Facioscapulohumeral Muscular Dystrophy.
    Himeda CL; Jones TI; Virbasius CM; Zhu LJ; Green MR; Jones PL
    Mol Ther; 2018 Jul; 26(7):1797-1807. PubMed ID: 29759937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digenic Inheritance in Rare Disorders and Mitochondrial Disease-Crossing the Frontier to a More Comprehensive Understanding of Etiology.
    Neuhofer CM; Prokisch H
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facioscapulohumeral muscular dystrophy.
    Fitzsimons RB
    Curr Opin Neurol; 1999 Oct; 12(5):501-11. PubMed ID: 10590886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facioscapulohumeral Muscular Dystrophy.
    DeSimone AM; Pakula A; Lek A; Emerson CP
    Compr Physiol; 2017 Sep; 7(4):1229-1279. PubMed ID: 28915324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid and accurate diagnosis of facioscapulohumeral muscular dystrophy.
    Goto K; Nishino I; Hayashi YK
    Neuromuscul Disord; 2006 Apr; 16(4):256-61. PubMed ID: 16545566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A hospital based epidemiological study of genetically determined muscle disease in south western Norway.
    Husebye SA; Rebne CB; Stokland AE; Sanaker PS; Bindoff LA
    Neuromuscul Disord; 2020 Mar; 30(3):181-185. PubMed ID: 32146000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.